Qingsu Cheng

Dr. Qingsu Cheng is an Assistant Professor of Biomedical Engineering at the University of Wisconsin-Milwaukee (UWM). Prior to UWM, he completed postdoctoral training at Lawrence Berkeley National Lab and served as a research scientist at the University of Nevada Reno. His research focuses on cancer therapeutics, microbiome analysis, and advanced imaging techniques. He leads the Cancer Therapeutics, Microbiome, and Imaging Lab, where he develops quantitative assays for organoid models and synthesizes C60-nucleic acid probes for live microorganism detection.

Education:

• PhD in Biomedical Engineering, University of South Carolina
• MS in Biochemical Engineering, Sichuan University
• BS in Bioengineering, Nanjing University of Technology

Research Interests: Dr. Cheng's work integrates bioimaging, nanotechnology, and cancer microenvironment studies. His lab investigates organoid-fibroblast interactions in breast cancer treatment, environmental effects on organoid formation, and microbiome applications in food safety. Key projects include developing quantum cascade laser microscopy for cancer differentiation and patent-pending C60 probes for microbial identification.

Professional Activities:

• NASA HRP Review Panel (2023)
• National Institutes of Health Review Panel ZRG1 OTC1-M(80) (2022)
• Co-founder of RiboFlare, a company commercializing microbial probes for food industry applications
• Referee for journals including Journal of Biomedical Materials Engineering and Carbohydrate Polymers

Labs & Teams: The Cancer Therapeutics, Microbiome, and Imaging Lab at UWM drives interdisciplinary research in biomedical engineering, combining experimental and computational approaches to address unmet clinical needs in oncology and diagnostics.